S&P 500   2,998.77 (+1.10%)
DOW   27,051.41 (+0.99%)
QQQ   193.56 (+1.29%)
AAPL   235.65 (-0.09%)
FB   189.45 (+3.37%)
MSFT   141.58 (+1.45%)
GOOGL   1,242.40 (+2.02%)
NVDA   198.02 (+6.16%)
MU   46.41 (+3.46%)
BABA   175.99 (+2.82%)
TSLA   258.51 (+0.60%)
AMD   30.78 (+0.79%)
T   37.94 (+1.25%)
ACB   3.78 (+7.69%)
PRI   123.81 (+1.93%)
NFLX   285.14 (-0.14%)
BAC   29.98 (+2.88%)
GILD   65.71 (+1.86%)
DIS   129.80 (+0.08%)
S&P 500   2,998.77 (+1.10%)
DOW   27,051.41 (+0.99%)
QQQ   193.56 (+1.29%)
AAPL   235.65 (-0.09%)
FB   189.45 (+3.37%)
MSFT   141.58 (+1.45%)
GOOGL   1,242.40 (+2.02%)
NVDA   198.02 (+6.16%)
MU   46.41 (+3.46%)
BABA   175.99 (+2.82%)
TSLA   258.51 (+0.60%)
AMD   30.78 (+0.79%)
T   37.94 (+1.25%)
ACB   3.78 (+7.69%)
PRI   123.81 (+1.93%)
NFLX   285.14 (-0.14%)
BAC   29.98 (+2.88%)
GILD   65.71 (+1.86%)
DIS   129.80 (+0.08%)
Log in

Immunodiagnostic Systems Stock Price, News & Analysis (LON:IDH)

GBX 270
0.00 (0.00 %)
(As of 10/15/2019 01:29 PM ET)
Today's Range
254
Now: GBX 270
270.14
50-Day Range
200
MA: GBX 215.72
270
52-Week Range
160
Now: GBX 270
240
Volume20,580 shs
Average Volume1,203 shs
Market Capitalization£77.72 million
P/E Ratio100.00
Dividend Yield0.32%
BetaN/A
Immunodiagnostic Systems Holdings PLC develops, manufactures, and sells in-vitro diagnostic tests to the clinical laboratory market in the United Kingdom, the United States, Germany, France, and internationally. It develops, manufactures, and markets immunoassays and automated immunoanalyser technologies to provide diagnostic outcomes for patients. It offers IDS-iSYS multi-discipline automated systems, which is based on chemiluminescence and absorbency technology is used for immunoassay testing. Read More…

Industry, Sector and Symbol

Industry Medical Appliances & Equipment
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+44-191-5190660

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£38.51 million
Cash FlowGBX 110.41 per share
Book ValueGBX 191.80 per share

Profitability

Miscellaneous

Employees283
Market Cap£77.72 million
Next Earnings DateN/A
OptionableNot Optionable

Receive IDH News and Ratings via Email

Sign-up to receive the latest news and ratings for IDH and its competitors with MarketBeat's FREE daily newsletter.


Immunodiagnostic Systems (LON:IDH) Frequently Asked Questions

What is Immunodiagnostic Systems' stock symbol?

Immunodiagnostic Systems trades on the London Stock Exchange (LON) under the ticker symbol "IDH."

How often does Immunodiagnostic Systems pay dividends? What is the dividend yield for Immunodiagnostic Systems?

Immunodiagnostic Systems declared a dividend on Wednesday, June 19th. Shareholders of record on Thursday, July 18th will be paid a dividend of GBX 0.70 per share on Friday, August 16th. This represents a yield of 0.37%. The ex-dividend date of this dividend is Thursday, July 18th. The official announcement can be seen at this link. View Immunodiagnostic Systems' Dividend History.

How were Immunodiagnostic Systems' earnings last quarter?

Immunodiagnostic Systems Holdings PLC (LON:IDH) issued its earnings results on Wednesday, June, 20th. The company reported $5.70 EPS for the quarter, beating the Zacks' consensus estimate of $2.60 by $3.10. View Immunodiagnostic Systems' Earnings History.

Has Immunodiagnostic Systems been receiving favorable news coverage?

Press coverage about IDH stock has trended somewhat negative on Tuesday, InfoTrie Sentiment reports. InfoTrie identifies negative and positive news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Immunodiagnostic Systems earned a news sentiment score of -1.4 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the near term. View News Stories for Immunodiagnostic Systems.

Who are some of Immunodiagnostic Systems' key competitors?

What other stocks do shareholders of Immunodiagnostic Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Immunodiagnostic Systems investors own include Dechra Pharmaceuticals (DPH), Redrow (RDW), iShares Nasdaq Biotechnology ETF (IBB), WisdomTree U.S. Multifactor Fund (USMF), Tp Icap (TCAP), Telford Homes (TEF), Netflix (NFLX), SYSCO (SYY), Arcontech Group (ARC) and Alliance Pharma (APH).

Who are Immunodiagnostic Systems' key executives?

Immunodiagnostic Systems' management team includes the folowing people:
  • Mr. Jaap Stuut, CEO & Director (Age 49)
  • Mr. Paul J. Martin, Group Fin. Director, Company Sec. & Director
  • Nicola Mitton, Group HR Director
  • Mr. Ed Coombes, Head Of Bus. Devel. - Instrumentation (Age 48)
  • Dr. Rudolf Schemer, CEO of GeschTMaftsfuhrer at IDS GmbH Frankfurt & Country Mang. of Germany Region (Age 58)

How do I buy shares of Immunodiagnostic Systems?

Shares of IDH and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Immunodiagnostic Systems' stock price today?

One share of IDH stock can currently be purchased for approximately GBX 270.

How big of a company is Immunodiagnostic Systems?

Immunodiagnostic Systems has a market capitalization of £77.72 million and generates £38.51 million in revenue each year. Immunodiagnostic Systems employs 283 workers across the globe.View Additional Information About Immunodiagnostic Systems.

What is Immunodiagnostic Systems' official website?

The official website for Immunodiagnostic Systems is http://www.idsplc.com/.

How can I contact Immunodiagnostic Systems?

Immunodiagnostic Systems' mailing address is 10 Didcot Way, BOLDON, NE35 9PD, United Kingdom. The company can be reached via phone at +44-191-5190660.


MarketBeat Community Rating for Immunodiagnostic Systems (LON IDH)

Community Ranking:  1.6 out of 5 (star)
Outperform Votes:  91 (Vote Outperform)
Underperform Votes:  187 (Vote Underperform)
Total Votes:  278
MarketBeat's community ratings are surveys of what our community members think about Immunodiagnostic Systems and other stocks. Vote "Outperform" if you believe IDH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IDH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/15/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel